Overexpression of a glucokinase point mutant in the treatment of diabetes mellitus
Glucokinase (GCK) is an important enzyme critical for glucose metabolism, and has been targeted as such in the pursuit of a cure for diabetes mellitus. We show that streptozotocin (STZ)-induced diabetic murine model exhibits low GCK expression with high blood glucose levels; moreover, aggravated glo...
Main Authors: | Lu, G, Teng, X, Zheng, Z, Zhang, R, Peng, L, Zheng, F, Liu, J, Huang, H, Xiong, H |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827006/ |
Similar Items
-
Polymorphism of Glucokinase Gene in Non-Insulin Dependent Diabetes Mellitus
by: Kim, Deog-Yoon, et al.
Published: (1994) -
Role of Glucokinase in the Subcellular Localization of Glucokinase Regulatory Protein
by: Jin, Ling, et al.
Published: (2015) -
Susceptibility of Glucokinase-MODY Mutants to Inactivation by Oxidative Stress in Pancreatic β-Cells
by: Cullen, Kirsty S., et al.
Published: (2011) -
Conformational Transition Pathway in the Activation Process of Allosteric Glucokinase
by: Huang, Min, et al.
Published: (2013) -
Decreased expression of hepatic glucokinase in type 2 diabetes
by: Haeusler, Rebecca A., et al.
Published: (2014)